Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events

BACKGROUNDThe hemodynamic alterations induced by the impairment of renal function explain only in part the development of left ventricular hypertrophy in patients with chronic kidney disease (CKD), who are theoretically exposed to an inappropriate high growth of left ventricular mass (iLVM) due to t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hypertension 2011-03, Vol.29 (3), p.565-573
Hauptverfasser: Cioffi, Giovanni, Tarantini, Luigi, Frizzi, Roberto, Stefenelli, Carlo, Russo, Tiziano E, Selmi, Alessandro, Toller, Chiara, Furlanello, Francesco, de Simone, Giovanni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 573
container_issue 3
container_start_page 565
container_title Journal of hypertension
container_volume 29
creator Cioffi, Giovanni
Tarantini, Luigi
Frizzi, Roberto
Stefenelli, Carlo
Russo, Tiziano E
Selmi, Alessandro
Toller, Chiara
Furlanello, Francesco
de Simone, Giovanni
description BACKGROUNDThe hemodynamic alterations induced by the impairment of renal function explain only in part the development of left ventricular hypertrophy in patients with chronic kidney disease (CKD), who are theoretically exposed to an inappropriate high growth of left ventricular mass (iLVM) due to the activation of neuro-hormonal stressors. Few data are available on the relations between iLVM and renal function. STUDY DESIGN AND MEASUREMENTSThree hundred and forty individuals at increased risk for cardiovascular events underwent assessment of renal function by the estimation of glomerular filtration rate (eGFR) and echocardiography227 patients had stages 1–2 CKD (eGFR ≥60 ml/min per 1.73 m), and 113 stages 3–5 (eGFR
doi_str_mv 10.1097/HJH.0b013e3283424188
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_851751787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>851751787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3858-2b50e3f91a2fa44b315c261b78993c3ce086ff77f6464c2fc3482e133cf1eb283</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS1ERUPhDRDyBnU1rX_HniWKKAFVYgPrkcdzTUycmeA7k9BH4K1xSCgSC6QreXG-c691DiGvOLvhrDG3q4-rG9YxLkEKK5VQ3NonZMGVkZXWjX1KFkzUsqqlFpfkOeI3xphtjHxGLgXnmtWyXpCfy3Ueh-jpJvYDPNA-IjgECin6OCGFHx4Q4x5oHHz-LcWBJggT3cMw5ejn5DLdOkT6NY-HaX3Ud26KRUXqpkdfT3PEDQ1jpt7lPo57hyczHDfhC3IRXEJ4eX6vyJe7d5-Xq-r-0_sPy7f3lZdW20p0moEMDXciOKU6ybUXNe-MbRrppQdm6xCMCbWqlRfBS2UFcCl94NCVpK7I9WnvLo_fZ8Cp3Ub0kJIbYJyxtZqbMtYUUp1In0fEDKHd5bh1-aHlrD120JYO2n87KLbX5wNzt4X-0fQn9AK8OQMlAZdCdoOP-JeTtqkN04WzJ-4wpgkybtJ8gNyuwaVp_f8__AJlW6Qd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>851751787</pqid></control><display><type>article</type><title>Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Cioffi, Giovanni ; Tarantini, Luigi ; Frizzi, Roberto ; Stefenelli, Carlo ; Russo, Tiziano E ; Selmi, Alessandro ; Toller, Chiara ; Furlanello, Francesco ; de Simone, Giovanni</creator><creatorcontrib>Cioffi, Giovanni ; Tarantini, Luigi ; Frizzi, Roberto ; Stefenelli, Carlo ; Russo, Tiziano E ; Selmi, Alessandro ; Toller, Chiara ; Furlanello, Francesco ; de Simone, Giovanni</creatorcontrib><description>BACKGROUNDThe hemodynamic alterations induced by the impairment of renal function explain only in part the development of left ventricular hypertrophy in patients with chronic kidney disease (CKD), who are theoretically exposed to an inappropriate high growth of left ventricular mass (iLVM) due to the activation of neuro-hormonal stressors. Few data are available on the relations between iLVM and renal function. STUDY DESIGN AND MEASUREMENTSThree hundred and forty individuals at increased risk for cardiovascular events underwent assessment of renal function by the estimation of glomerular filtration rate (eGFR) and echocardiography227 patients had stages 1–2 CKD (eGFR ≥60 ml/min per 1.73 m), and 113 stages 3–5 (eGFR &lt;60 ml/min per 1.73 m). LVM was predicted in each patient from height, sex and stroke work using a validated equation. iLVM was defined as LVM more than 28% of the predicted value. Sixty-eight healthy individuals served as controls. RESULTSiLVM was detected in seven controls (10%) and in 146 study patients (43%). There was an inverse relation between observed/predicted LVM ratio and eGFR (r 0.54, P &lt; 0.001). In linear regression analysis, iLVM was related to eGFR (β 0.40), relative wall thickness (β 0.29), diabetes (β 0.14), and maximal left atrial volume (β 0.25) (all P &lt; 0.001). Prevalence of iLVM was 10% in patients in stage-1 CKD, 31% in stage 2, 67% in stage 3, and 100% in stages 4 and 5. CONCLUSIONIn patients at increased risk for cardiovascular events, iLVM is strongly related to the presence and magnitude of CKD. Further longitudinal studies are needed to evaluate the prognostic value of the coexistence of iLVM and CKD.</description><identifier>ISSN: 0263-6352</identifier><identifier>EISSN: 1473-5598</identifier><identifier>DOI: 10.1097/HJH.0b013e3283424188</identifier><identifier>PMID: 21150636</identifier><identifier>CODEN: JOHYD3</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; Aged ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular Diseases - etiology ; Chronic Disease ; Diabetes Mellitus - pathology ; Experimental diseases ; Female ; Humans ; Hypertrophy, Left Ventricular - epidemiology ; Hypertrophy, Left Ventricular - etiology ; Hypertrophy, Left Ventricular - pathology ; Kidney Diseases - complications ; Linear Models ; Male ; Medical sciences ; Middle Aged ; Prevalence ; Risk ; Ventricular Function, Left</subject><ispartof>Journal of hypertension, 2011-03, Vol.29 (3), p.565-573</ispartof><rights>2011 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3858-2b50e3f91a2fa44b315c261b78993c3ce086ff77f6464c2fc3482e133cf1eb283</citedby><cites>FETCH-LOGICAL-c3858-2b50e3f91a2fa44b315c261b78993c3ce086ff77f6464c2fc3482e133cf1eb283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23896705$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21150636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cioffi, Giovanni</creatorcontrib><creatorcontrib>Tarantini, Luigi</creatorcontrib><creatorcontrib>Frizzi, Roberto</creatorcontrib><creatorcontrib>Stefenelli, Carlo</creatorcontrib><creatorcontrib>Russo, Tiziano E</creatorcontrib><creatorcontrib>Selmi, Alessandro</creatorcontrib><creatorcontrib>Toller, Chiara</creatorcontrib><creatorcontrib>Furlanello, Francesco</creatorcontrib><creatorcontrib>de Simone, Giovanni</creatorcontrib><title>Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events</title><title>Journal of hypertension</title><addtitle>J Hypertens</addtitle><description>BACKGROUNDThe hemodynamic alterations induced by the impairment of renal function explain only in part the development of left ventricular hypertrophy in patients with chronic kidney disease (CKD), who are theoretically exposed to an inappropriate high growth of left ventricular mass (iLVM) due to the activation of neuro-hormonal stressors. Few data are available on the relations between iLVM and renal function. STUDY DESIGN AND MEASUREMENTSThree hundred and forty individuals at increased risk for cardiovascular events underwent assessment of renal function by the estimation of glomerular filtration rate (eGFR) and echocardiography227 patients had stages 1–2 CKD (eGFR ≥60 ml/min per 1.73 m), and 113 stages 3–5 (eGFR &lt;60 ml/min per 1.73 m). LVM was predicted in each patient from height, sex and stroke work using a validated equation. iLVM was defined as LVM more than 28% of the predicted value. Sixty-eight healthy individuals served as controls. RESULTSiLVM was detected in seven controls (10%) and in 146 study patients (43%). There was an inverse relation between observed/predicted LVM ratio and eGFR (r 0.54, P &lt; 0.001). In linear regression analysis, iLVM was related to eGFR (β 0.40), relative wall thickness (β 0.29), diabetes (β 0.14), and maximal left atrial volume (β 0.25) (all P &lt; 0.001). Prevalence of iLVM was 10% in patients in stage-1 CKD, 31% in stage 2, 67% in stage 3, and 100% in stages 4 and 5. CONCLUSIONIn patients at increased risk for cardiovascular events, iLVM is strongly related to the presence and magnitude of CKD. Further longitudinal studies are needed to evaluate the prognostic value of the coexistence of iLVM and CKD.</description><subject>Adult</subject><subject>Aged</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Chronic Disease</subject><subject>Diabetes Mellitus - pathology</subject><subject>Experimental diseases</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertrophy, Left Ventricular - epidemiology</subject><subject>Hypertrophy, Left Ventricular - etiology</subject><subject>Hypertrophy, Left Ventricular - pathology</subject><subject>Kidney Diseases - complications</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Risk</subject><subject>Ventricular Function, Left</subject><issn>0263-6352</issn><issn>1473-5598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1uEzEUhS1ERUPhDRDyBnU1rX_HniWKKAFVYgPrkcdzTUycmeA7k9BH4K1xSCgSC6QreXG-c691DiGvOLvhrDG3q4-rG9YxLkEKK5VQ3NonZMGVkZXWjX1KFkzUsqqlFpfkOeI3xphtjHxGLgXnmtWyXpCfy3Ueh-jpJvYDPNA-IjgECin6OCGFHx4Q4x5oHHz-LcWBJggT3cMw5ejn5DLdOkT6NY-HaX3Ud26KRUXqpkdfT3PEDQ1jpt7lPo57hyczHDfhC3IRXEJ4eX6vyJe7d5-Xq-r-0_sPy7f3lZdW20p0moEMDXciOKU6ybUXNe-MbRrppQdm6xCMCbWqlRfBS2UFcCl94NCVpK7I9WnvLo_fZ8Cp3Ub0kJIbYJyxtZqbMtYUUp1In0fEDKHd5bh1-aHlrD120JYO2n87KLbX5wNzt4X-0fQn9AK8OQMlAZdCdoOP-JeTtqkN04WzJ-4wpgkybtJ8gNyuwaVp_f8__AJlW6Qd</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Cioffi, Giovanni</creator><creator>Tarantini, Luigi</creator><creator>Frizzi, Roberto</creator><creator>Stefenelli, Carlo</creator><creator>Russo, Tiziano E</creator><creator>Selmi, Alessandro</creator><creator>Toller, Chiara</creator><creator>Furlanello, Francesco</creator><creator>de Simone, Giovanni</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events</title><author>Cioffi, Giovanni ; Tarantini, Luigi ; Frizzi, Roberto ; Stefenelli, Carlo ; Russo, Tiziano E ; Selmi, Alessandro ; Toller, Chiara ; Furlanello, Francesco ; de Simone, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3858-2b50e3f91a2fa44b315c261b78993c3ce086ff77f6464c2fc3482e133cf1eb283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Chronic Disease</topic><topic>Diabetes Mellitus - pathology</topic><topic>Experimental diseases</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertrophy, Left Ventricular - epidemiology</topic><topic>Hypertrophy, Left Ventricular - etiology</topic><topic>Hypertrophy, Left Ventricular - pathology</topic><topic>Kidney Diseases - complications</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Risk</topic><topic>Ventricular Function, Left</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cioffi, Giovanni</creatorcontrib><creatorcontrib>Tarantini, Luigi</creatorcontrib><creatorcontrib>Frizzi, Roberto</creatorcontrib><creatorcontrib>Stefenelli, Carlo</creatorcontrib><creatorcontrib>Russo, Tiziano E</creatorcontrib><creatorcontrib>Selmi, Alessandro</creatorcontrib><creatorcontrib>Toller, Chiara</creatorcontrib><creatorcontrib>Furlanello, Francesco</creatorcontrib><creatorcontrib>de Simone, Giovanni</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cioffi, Giovanni</au><au>Tarantini, Luigi</au><au>Frizzi, Roberto</au><au>Stefenelli, Carlo</au><au>Russo, Tiziano E</au><au>Selmi, Alessandro</au><au>Toller, Chiara</au><au>Furlanello, Francesco</au><au>de Simone, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events</atitle><jtitle>Journal of hypertension</jtitle><addtitle>J Hypertens</addtitle><date>2011-03</date><risdate>2011</risdate><volume>29</volume><issue>3</issue><spage>565</spage><epage>573</epage><pages>565-573</pages><issn>0263-6352</issn><eissn>1473-5598</eissn><coden>JOHYD3</coden><abstract>BACKGROUNDThe hemodynamic alterations induced by the impairment of renal function explain only in part the development of left ventricular hypertrophy in patients with chronic kidney disease (CKD), who are theoretically exposed to an inappropriate high growth of left ventricular mass (iLVM) due to the activation of neuro-hormonal stressors. Few data are available on the relations between iLVM and renal function. STUDY DESIGN AND MEASUREMENTSThree hundred and forty individuals at increased risk for cardiovascular events underwent assessment of renal function by the estimation of glomerular filtration rate (eGFR) and echocardiography227 patients had stages 1–2 CKD (eGFR ≥60 ml/min per 1.73 m), and 113 stages 3–5 (eGFR &lt;60 ml/min per 1.73 m). LVM was predicted in each patient from height, sex and stroke work using a validated equation. iLVM was defined as LVM more than 28% of the predicted value. Sixty-eight healthy individuals served as controls. RESULTSiLVM was detected in seven controls (10%) and in 146 study patients (43%). There was an inverse relation between observed/predicted LVM ratio and eGFR (r 0.54, P &lt; 0.001). In linear regression analysis, iLVM was related to eGFR (β 0.40), relative wall thickness (β 0.29), diabetes (β 0.14), and maximal left atrial volume (β 0.25) (all P &lt; 0.001). Prevalence of iLVM was 10% in patients in stage-1 CKD, 31% in stage 2, 67% in stage 3, and 100% in stages 4 and 5. CONCLUSIONIn patients at increased risk for cardiovascular events, iLVM is strongly related to the presence and magnitude of CKD. Further longitudinal studies are needed to evaluate the prognostic value of the coexistence of iLVM and CKD.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>21150636</pmid><doi>10.1097/HJH.0b013e3283424188</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0263-6352
ispartof Journal of hypertension, 2011-03, Vol.29 (3), p.565-573
issn 0263-6352
1473-5598
language eng
recordid cdi_proquest_miscellaneous_851751787
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular Diseases - etiology
Chronic Disease
Diabetes Mellitus - pathology
Experimental diseases
Female
Humans
Hypertrophy, Left Ventricular - epidemiology
Hypertrophy, Left Ventricular - etiology
Hypertrophy, Left Ventricular - pathology
Kidney Diseases - complications
Linear Models
Male
Medical sciences
Middle Aged
Prevalence
Risk
Ventricular Function, Left
title Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A59%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20kidney%20disease%20elicits%20excessive%20increase%20in%20left%20ventricular%20mass%20growth%20in%20patients%20at%20increased%20risk%20for%20cardiovascular%20events&rft.jtitle=Journal%20of%20hypertension&rft.au=Cioffi,%20Giovanni&rft.date=2011-03&rft.volume=29&rft.issue=3&rft.spage=565&rft.epage=573&rft.pages=565-573&rft.issn=0263-6352&rft.eissn=1473-5598&rft.coden=JOHYD3&rft_id=info:doi/10.1097/HJH.0b013e3283424188&rft_dat=%3Cproquest_cross%3E851751787%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=851751787&rft_id=info:pmid/21150636&rfr_iscdi=true